Skip to main content
Log in

Management of rheumatic diseases in children

  • Symposium: Rheumatology Part I
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Rheumatic diseases are one of the common groups of chronic diseases of childhood. They are multifactorial in origin and tend to involve multiple organ systems. Consequently management of these diseases requires the expertise of many health and allied health professionals. This review article focuses on the medical management of three of the relatively common diseases: juvenile rheumatoid arthritis (JRA), systemic lupus erythematozus (SLE) and dermatomyositis (DM).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cassidy JT and Petty RE.Textbook of Pediartric Rheumatology 3rd ed. Philadelpia: W.B. Saunders Co, 1995.

    Google Scholar 

  2. Miller Me, ed. Pediatric Rheumatology.Pediatric Clinics of North America 1995; 42 (5).

  3. The Rheumatic Diseases of Childhood Proceedings of the First ARA Conference Arthritis Rheumatism 1977; 20: suppl 2.

  4. McInerny T. The role of general pediatrician in coordinating the care of children with chronic illness.Pediatr Clinics N Amer 1984; 31 (1): 199–209.

    CAS  Google Scholar 

  5. McCormick MC, Stemmler MM and Athreya BH. The impact of childhood rheumatic diseases on the family.Arthritis Rheum 1986; 29: 872–879.

    Article  PubMed  CAS  Google Scholar 

  6. King K and Hanson V. Psychosocial aspects of Juvenile Rheumatoid Arthritis.Pediatr Chnics N Amer 1986; 33 (5): 1221–1237.

    CAS  Google Scholar 

  7. Giannini EH and Cawkwell GD. Drug treatment in children with Juvenile rheumatoid arthritis: Past, present and future.Pediatr Clinics N Amer 1995; 42 (5): 1099–1125.

    CAS  Google Scholar 

  8. Athreya BH and Cassidy JT. Current status of the medical treatment of children with Juvenile rheumatoid Arthritis.Rheum Dis Clinics of N Amer 1991; 17 (4): 871–889.

    CAS  Google Scholar 

  9. Harris EH. Rheumatoid Arthritis: Pathophysiology and complications of therapy.N Engl J Med 1990; 322: 1277–1289.

    Article  PubMed  Google Scholar 

  10. Lang BA and Shore A. A review of current concepts on the pathogenesis of Juvenile Rheumatoid Arthritis.J Rheumatol 1990; 17 (suppl 21): 1–15.

    Google Scholar 

  11. Furst DE and Paulus HE. Aspirin and other nonsteroidal anti-inflammatory drugs in Arthritis and Allied Conditions. In: McCarty DJ and Koopman WJ, eds. 12th ed, Philadelphia: Lea and Febiger, 1993: 567–602.

    Google Scholar 

  12. Brewer EJ, Giannini EH, Person DA. Juvenile Rheumatoid Arthritis Vol VI Major Problems in Clinical Pediatrics Series II ed Philadelphia W.B. Saunders Co 1982: 125–184.

    Google Scholar 

  13. Doughty RA, Giesecke L, Athreya BH. Salicylate therapy in Juvenile Rheumatoid Arthritis: dose, serum level and toxicity.Amer J Dis Childr 1980; 134: 461–463.

    CAS  Google Scholar 

  14. Furst DE. Are there differences among nonsteroidal anti-inflammatory drugs? (A Review).Arthritis Rheum 1994; 37: 1–9.

    Article  PubMed  CAS  Google Scholar 

  15. Brooks PM, Day RO. Nonsteroidal anti-inflammatory drugs: differences and similarities.N Eng J Med 1991; 324: 1716–1725.

    Article  CAS  Google Scholar 

  16. Mitchell JA, Akarasereenont P, Thiemermann Cet al. Selectivity of nonsteroidal anti-infalmmatory drugs as inhibitors of constitutive and inducible cyclo-oxygenase.Proc Natal Acad Sci (USA) 1993; 90: 11,693–11,697.

    CAS  Google Scholar 

  17. Lovell DJ, Giannini EH, Brewer EJ. Time course of response to nonsteroidal anti-inflammatory drugs in Juvenile Rheumatoid Arthritis.Arthritis Rheum 1984; 27: 1433–1437.

    Article  PubMed  CAS  Google Scholar 

  18. Lichtnstein DR, Syngal S, Michael Wolf M. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract—The double-edged sword.Arthritis Rheum 1995; 38: 5–18.

    Article  Google Scholar 

  19. Muhlberg AE, Linz C, Bern Eet al. Identification of nonsteroidal anti-inflammatory drug-induced gastroduodenal injury in children with juvenile rheumatoid arthritis.J Pediatr 1993; 122: 647–649.

    Article  Google Scholar 

  20. Dowd JE, Cimaz R, Fink CW. Nonsteroidal anti-inflammatory drug-induced gastroduodenal injury in children.Arthritis Rheum 1995; 38: 1225–1231.

    Article  PubMed  CAS  Google Scholar 

  21. Keenan GK, Giannini EH, Athreya BH. Clinically significant gastropathy associated with nonsteroidal anti-inflammatory drug use in children with Juvenile Rheumatoid Arthritis.J Rheumatol 1995; 22: 1149–1151.

    PubMed  CAS  Google Scholar 

  22. Levy ML, Barron KS, Eichenfield AE, Honig P. Naproxen-induced pseudoporphyria: a distinctive photodermatitis.J Pediatr 1990; 117: 660–664.

    Article  PubMed  CAS  Google Scholar 

  23. Szer I, Goldenstein-Schainberg C, Kurtin P. Paucity of renal complications associated with nonsteroidal anti-inflammatory drugs in children with chronic arthritis.J Pediatr 1991; 119: 815–817.

    Article  PubMed  CAS  Google Scholar 

  24. Garella S, Matarese RA. Renal effects of prostaglandins and clinical adverse effects of nonsteroidal anti-inflammatory agents.Medicine 1984; 63: 165–181.

    Article  PubMed  CAS  Google Scholar 

  25. Giannini EH, Brewer EJ, Kuzmina Net al. Methotrexate in resistant juvenile rheumatoid arthritis: results of the USA-USSR double-blind, placebo controlled trial.N Eng J Med 1991; 326: 1043–1049.

    Article  Google Scholar 

  26. Gutierrez-Urena S, Espinoza L. Methotrexate: the agent of choice for chronic inflammatory disorders: a perspective ten years later (Editoria).Clin Exptl Rheumatol 1995; 13: 281–284.

    CAS  Google Scholar 

  27. Cronstein BN, Naime D, Ostad E. The anti-inflammatory mechanism of methotrexate. Increased adenosine release at inflammed sites diminishes leucocyte accumulation in a in vitro model of inflammation.J Clin Invest 1993; 92: 2675–2682.

    Article  PubMed  CAS  Google Scholar 

  28. Alarcon GS, Lopez-Mendez A, Walter Jet al. Radiographic evidence of disease progression in methotrexate-treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta analysis.J Rheumatol 1992; 19: 1868–1873.

    PubMed  CAS  Google Scholar 

  29. Weinblatt ME, Weissman BN, Holdsworth DFet al. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84 month update.Arthrits Rheum 1992; 35: 129–137.

    Article  CAS  Google Scholar 

  30. Whiting-O’.Keefe QE, Fye EH, Sack KD. Methotrexate and histologic hepatic abnormalities: a meta analysis.Amer J Med 1991; 90: 711–716.

    CAS  Google Scholar 

  31. Keim D, Ragsdale C, Heidelberger K, Sullivan DB. Hepatic fibrosis with the use of methotrexate for juvenile rheumtoid arthritis.J Rheumatol 1990; 17: 846–848.

    PubMed  CAS  Google Scholar 

  32. Douglas Craham L, Myones BL, Rivas-Chicon RF, Pachman LM. Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis.J Pediatr 1992; 120: 468–473.

    Article  Google Scholar 

  33. Brewer EJ, Giannini EH. Kuzmina Net al. Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis.N Eng J Med 1986; 314: 1269–1276.

    Article  CAS  Google Scholar 

  34. Laaksonen AC, Koskiahde V, Juva K. Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus.Scand J Rheumatol 1974; 3: 103–108.

    PubMed  CAS  Google Scholar 

  35. Brewer EJ, Giannini EH, Barkley E. Gold therapy in the management of juvenile rheumatoid arthritis.Arthritis Rheum 1980; 23: 404–411.

    Article  PubMed  Google Scholar 

  36. Giannini EH, Barron KS, Spencer CHet al. Auranofin therapy for juvenile rheumatoid arthritis: results of the five year open label extension trial.J Rheumatol 1991; 18: 1240–1242.

    PubMed  CAS  Google Scholar 

  37. Prieur AM, Piussan C, Manigne Pet al. Evaluation of d-penicillamine in juvenile chronic arthritis: a double-blind multicenter study.Arthritis Rheum 1985; 28: 376–382.

    Article  PubMed  CAS  Google Scholar 

  38. Joos R, Veys EM, Mielants Het al. Sulfasalazine treatment in juvenile chronic arthritis: an open study.J Rheumatol 1991; 18: 880–884.

    PubMed  CAS  Google Scholar 

  39. Hertzberger-ten Cate, Cats A. Toxicity of sulfasalazine in systemic juvenile chronic arthritis.Clin Exptl Rheumatol 1991; 9: 85–88.

    Google Scholar 

  40. Kimberly RP. Mechanism of action, dosage schedule and side-effects of steroid therapy.Current opinion in Rheumatol 1991; 3: 373–379.

    Article  CAS  Google Scholar 

  41. Boumpas DT. Glucocorticoid therapy for immune mediated diseases; basic and clinical correlates. NIH Conference.Ann Int Med 1993; 119: 1198–1208.

    PubMed  CAS  Google Scholar 

  42. Priuer AM. The place of corticosteroid therapy in juvenile chronic arthritis in 1992.J Rheumatol 1993; 20 (suppl 37): 32–34.

    Google Scholar 

  43. Pentikainen PJ. Pharmacological aspects of corticosteroid pulse therapy in high dose intravenous corticosteriod therapy of Systemic Lupus Erythematosus and Primary Crescentic Rapidly Progressive Glomerulonephritis.Scand J Rheumatol 1984; (Suppl 54): 6–9.

    CAS  Google Scholar 

  44. Earley A, Cuttica RJ, McCullough, Ansell BM. Triamcinalone into the knee joint in juvenile chronic arthritis.Clin Exptl Rheumatol 1988; 6: 153–155.

    CAS  Google Scholar 

  45. Loftus J, Allen R, Hesp Ret al. Randomised double-blind trial of Deflazacort versus prednisone in juvenile chronic (rheumatoid) arthritis: a relatively bonesparing effect of Deflazacort.Pediatr 1991; 88: 428–436.

    CAS  Google Scholar 

  46. Schaller JG. Therapy for childhood rheumatic diseases. Have we been doing enough?.Arthritis Rheum 1993; 36: 65–70.

    Article  PubMed  CAS  Google Scholar 

  47. Lehman TJA. Aggressive therapy for childhood rheumatic diseases. When are immunosuppressives appropriate?Arthritis Rheum 1993; 36: 71–74.

    Article  PubMed  CAS  Google Scholar 

  48. Silverman ED, Laxer RM, Greenwald Met al. Intravenous gamma globulin therapy in systemic juvenile rheumatoid arthritis.Arthritis Rheum 1990; 33: 1015–1022.

    Article  PubMed  CAS  Google Scholar 

  49. Silverman ED, Cawkwell GD, Lovell DJet al. Intravenous immune globulin in the treatment of sytemic juvenile rheumatoid arthritis; a randomized placebo-controlled trial.J Rheumatol 1994; 21: 2353–2358.

    PubMed  CAS  Google Scholar 

  50. Prieur AM, Adleff A, Debre Met al. High dose immun globulin therapy in severe juvenile rheumatoid arthritis: long term folow-up in 16 pateints.Clin Exptl Rheumatol 1990; 8: 603–609.

    CAS  Google Scholar 

  51. Bjoro K, Froland SS, Yun Zet al. Hepatitis C infection in patients wiht primary hypogammglobulinemia after therapy with contaminated immune globulin.N Eng J Med 1994; 331: 1607–1611.

    Article  CAS  Google Scholar 

  52. Duhem C, DiCato MA, Ros F. Side-effects of intravenous immune globulin (Review).Clin Exptl Immunol 1994; 97 (suppl 1): 79–83.

    Google Scholar 

  53. Ostensen M, Hoyeraal HM and Kass E. Tolerance of cyclosporine A in children with refractory juvenile rheumatoid arthritis.J Rheumatol 1988; 15: 1536–1538.

    PubMed  CAS  Google Scholar 

  54. Pistoia V, Buoncompagni A, Scribaniset al. Cyclosporine in the treatment of juvenile chronic arthritis and polymyositis-dermatomyositis-results of a preliminary study.Clin Exptl Rheumatol 1993; 11: 203–208.

    CAS  Google Scholar 

  55. Jaffe IA. Combination therapy of rheumatoid arthritis—Rationale and overview.J Rheumatol 1990; 17 (Suppl 25): 24–27.

    Google Scholar 

  56. Watts RA, Isaacs JD. Immunotherapy of rheumatoid arthritis.Ann Rheum Dis 1992; 51: 577–579.

    PubMed  CAS  Google Scholar 

  57. Scull SC, Dow MB, Athreya BH. Physical and occupational therapy for children with rheumatic diseases.Ped Clin N Amer 33 (5): 1053–1078.

  58. Emery H, Bowyer S, Sisung E. Rehabilitation of the child with a rheumatic disease.Ped Clin N Amer 1995; 42 (5): 1263–1284.

    CAS  Google Scholar 

  59. Hicks JE, NIcholas JJ, Swezey RL (eds).Handbook of Rehabilitative Rheumatology of the American Rheumatism Association. Bayport NY: Contact Association International Publishers, 1988.

    Google Scholar 

  60. Arden GP, Ansell BM.Surgical management of Juvenile chronic arthritis. London: Academic Press, 1978.

    Google Scholar 

  61. Hyman BS, Gregg JR. Arthroplasty of the hip and knee in juvenile rheumatoid arthritis.Rheum Clin N Amer 1991; 17 (4): 971–984.

    CAS  Google Scholar 

  62. Athreya BH. Systemic Lupus Erythematosus. In: Burg FD, Inglefinger JR, Wald ER, Polin RA, eds.Current Pediatric Therapy 15th Ed, Philadelphia: W.B. Saunders Co, 1995: 388–389.

    Google Scholar 

  63. Lehman TJA. A practical guide to systemic lupus erythematosus.Ped Clinics N Amer 1995; 42 (5): 1223–1228.

    CAS  Google Scholar 

  64. Boumpas DT, Austin HA, Vaughn EM et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.Lancet 1992; 340: 741–745.

    Article  PubMed  CAS  Google Scholar 

  65. Ansell BM. Juvenile Dermatomyositis.Rheum Dis Clinics N Amer 1991; 17 (4): 931–942.

    CAS  Google Scholar 

  66. Pachman LM. Juvenile Dermatomyositis: Pathophysiology and disease expression.Ped Clinics N Amer 1995; 42 (5): 1071–1098.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Athieya, B.H. Management of rheumatic diseases in children. Indian J Pediatr 63, 305–321 (1996). https://doi.org/10.1007/BF02751523

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02751523

Key words

Navigation